-
1
-
-
84864047454
-
Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia
-
Leung W, Pui C-H, Coustan-Smith E, et al. Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia. Blood. 2012;120(2):468-472.
-
(2012)
Blood
, vol.120
, Issue.2
, pp. 468-472
-
-
Leung, W.1
Pui, C.-H.2
Coustan-Smith, E.3
-
2
-
-
77955503223
-
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Disease-specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, acute leukemias, and myelodysplastic syndromes
-
Erratum in: Biol Blood Marrow Transplant. 2010;16(12):1752
-
Kröger N, Bacher U, Bader P, et al. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, acute leukemias, and myelodysplastic syndromes. Biol Blood Marrow Transplant. 2010;16(9):1187-1211. Erratum in: Biol Blood Marrow Transplant. 2010;16(12):1752.
-
(2010)
Biol Blood Marrow Transplant
, vol.16
, Issue.9
, pp. 1187-1211
-
-
Kröger, N.1
Bacher, U.2
Bader, P.3
-
3
-
-
77956309607
-
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Disease-specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part II: Chronic leukemias, myeloproliferative neoplasms, and lymphoid malignancies
-
Kröger N, Bacher U, Bader P, et al. NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Disease-specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part II: Chronic leukemias, myeloproliferative neoplasms, and lymphoid malignancies. Biol Blood Marrow Transplant. 2010;16(10):1325-1346.
-
(2010)
Biol Blood Marrow Transplant
, vol.16
, Issue.10
, pp. 1325-1346
-
-
Kröger, N.1
Bacher, U.2
Bader, P.3
-
4
-
-
33745603988
-
Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: Review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results
-
DOI 10.1182/blood-2006-01-0092
-
Hughes T, Deininger M, Hochhaus A, et al. Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results. Blood. 2006;108(1):28-37. (Pubitemid 43990609)
-
(2006)
Blood
, vol.108
, Issue.1
, pp. 28-37
-
-
Hughes, T.1
Deininger, M.2
Hochhaus, A.3
Branford, S.4
Radich, J.5
Kaeda, J.6
Baccarani, M.7
Cortes, J.8
Cross, N.C.P.9
Druker, B.J.10
Gabert, J.11
Grimwade, D.12
Hehlmann, R.13
Kamel-Reid, S.14
Lipton, J.H.15
Longtine, J.16
Martinelli, G.17
Saglio, G.18
Soverini, S.19
Stock, W.20
Goldman, J.M.21
more..
-
5
-
-
58549091682
-
Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: The ALL-REZBFM Study Group
-
Bader P, Kreyenberg H, Henze GH, et al. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZBFM Study Group. J Clin Oncol. 2009;27(3):377-384.
-
(2009)
J Clin Oncol
, vol.27
, Issue.3
, pp. 377-384
-
-
Bader, P.1
Kreyenberg, H.2
Henze, G.H.3
-
6
-
-
0242367154
-
Predictors of relapse and overall survival in Philadelphia chromosomepositive acute lymphoblastic leukemia after transplantation
-
Stirewalt DL, Guthrie KA, Beppu L, et al. Predictors of relapse and overall survival in Philadelphia chromosomepositive acute lymphoblastic leukemia after transplantation. Biol Blood Marrow Transplant. 2003;9(3):206-212.
-
(2003)
Biol Blood Marrow Transplant
, vol.9
, Issue.3
, pp. 206-212
-
-
Stirewalt, D.L.1
Guthrie, K.A.2
Beppu, L.3
-
7
-
-
34447335130
-
Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia
-
DOI 10.3324/haematol.10965
-
Spinelli O, Peruta B, Tosi M, et al. Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia. Haematologica. 2007;92(5):612-618. (Pubitemid 350144263)
-
(2007)
Haematologica
, vol.92
, Issue.5
, pp. 612-618
-
-
Spinelli, O.1
Peruta, B.2
Tosi, M.3
Guerini, V.4
Salvi, A.5
Zanotti, M.C.6
Oldani, E.7
Grassi, A.8
Intermesoli, T.9
Mico, C.10
Rossi, G.11
Fabris, P.12
Lambertenghi-Deliliers, G.13
Angelucci, E.14
Barbui, T.15
Bassan, R.16
Rambaldi, A.17
-
8
-
-
79952757082
-
Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia
-
Walter RB, Gooley TA, Wood BL, et al. Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia. J Clin Oncol. 2011;29(9):1190-1197.
-
(2011)
J Clin Oncol
, vol.29
, Issue.9
, pp. 1190-1197
-
-
Walter, R.B.1
Gooley, T.A.2
Wood, B.L.3
-
9
-
-
78649429727
-
Reduced mortality after allogeneic hematopoietic-cell transplantation
-
Gooley TA, Chien JW, Pergam SA, et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. New Engl J Med. 2010;363(22):2091-2101.
-
(2010)
New Engl J Med
, vol.363
, Issue.22
, pp. 2091-2101
-
-
Gooley, T.A.1
Chien, J.W.2
Pergam, S.A.3
-
10
-
-
79952609273
-
National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Summary and Recommendations from the Organizing Committee
-
Bishop MR, Alyea EP III, Cairo MS, et al. National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Summary and Recommendations from the Organizing Committee. Biol Blood Marrow Transplant. 2011;17(4):443-454.
-
(2011)
Biol Blood Marrow Transplant
, vol.17
, Issue.4
, pp. 443-454
-
-
Bishop, M.R.1
Alyea III, E.P.2
Cairo, M.S.3
-
11
-
-
84861120541
-
Highthroughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia
-
Wu D, Sherwood A, Fromm JR, et al. Highthroughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia. Sci Transl Med. 2012;4(134):134ra63.
-
(2012)
Sci Transl Med
, vol.4
, Issue.134
-
-
Wu, D.1
Sherwood, A.2
Fromm, J.R.3
-
12
-
-
79959450187
-
New markers for minimal residual disease detection in acute lymphoblastic leukemia
-
Coustan-Smith E, Song G, Clark C, et al. New markers for minimal residual disease detection in acute lymphoblastic leukemia. Blood. 2011;117(23):6267- 6276.
-
(2011)
Blood
, vol.117
, Issue.23
, pp. 6267-6276
-
-
Coustan-Smith, E.1
Song, G.2
Clark, C.3
|